Latest News & Features
Americas
Following the CRISPR/Cas9 patent hearing on December 6 between The Broad Institute and University of California, Berkeley, it is very unlikely that the case will end at the US Patent and Trademark Office, according to one lawyer. 8 December 2016
Americas
The US Court of Appeals for the Federal Circuit has vacated and remanded a patent suit which NuVasive had appealed against after having patent claims invalidated. 8 December 2016
Biotechnology
Heli Pihlajamaa, director of patent law at the European Patent Office, yesterday outlined the latest developments in the area of plant patentability. 8 December 2016
Big Pharma
Data exclusivity should be considered as part of an intellectual property portfolio, according to a speaker at the Life Sciences Patents Network Europe conference. 8 December 2016
Americas
3D printing will shake up the world of intellectual property law, providing numerous opportunities for those who are prepared, but also risks to those who aren’t. 8 December 2016
Americas
President-elect Donald Trump’s announcement that he will withdraw the US from the Trans-Pacific Partnership is a “detriment” to US companies in terms of enforcing their patent rights in other jurisdictions. 8 December 2016
Big Pharma
Drugs companies that acquire other businesses should act cautiously after the deal has been completed, because of potential differences in patent strategy, an Eli Lilly counsel has said. 7 December 2016
Big Pharma
The Unified Patent Court Agreement has not quite reached a safe harbour yet, but it is close. 7 December 2016
Americas
The complications surrounding second medical use patents risks the pharmaceutical industry again becoming a “big, bad wolf”. 7 December 2016
Big Pharma
Intellectual property is the lifeblood of the life sciences industry and innovation is key, according to Nicola Dagg, head of Allen & Overy’s IP litigation practice in London. 7 December 2016